Back
Also listed as
GELYF
OTC
Day Range
$49.90
$52.52
52-Week Range
$33.30
$53.40
Volume
27,666
50D / 200D Avg
$43.05
/
$45.53
Prev Close
$48.66
Price History
Financial Trends
Peer Comparison
vs Consumer Cyclical sector median (609 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 12.0 | 11.1 |
| P/B | 2.1 | 1.4 |
| ROE % | 4.7 | 10.7 |
| Net Margin % | 4.9 | 5.1 |
| Rev Growth 5Y % | -17.1 | 8.2 |
| D/E | 0.3 | 0.8 |
Key Takeaways
Revenue declined -17.08% annually over 5 years
Earnings declined -85.90% over the past year
ROE of 4.69% is below average
Debt/Equity of 0.25 — conservative balance sheet
Generating 6.10B in free cash flow
P/E of 12.03 — trading at a low valuation
Growth
Revenue Growth (5Y)
-17.08%
Revenue (1Y)-80.01%
Earnings (1Y)-85.90%
FCF Growth (3Y)-6.79%
Quality
Return on Equity
4.69%
ROIC7.27%
Net Margin4.88%
Op. Margin3.34%
Safety
Debt / Equity
0.25
Current Ratio0.89
Interest Coverage16.51
Valuation
P/E Ratio
12.03
P/B Ratio2.13
EV/EBITDA13.57
Dividend Yield0.38%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -80.01% | Revenue Growth (3Y) | -48.23% |
| Earnings Growth (1Y) | -85.90% | Earnings Growth (3Y) | -33.54% |
| Revenue Growth (5Y) | -17.08% | Earnings Growth (5Y) | -16.61% |
| Profitability | |||
| Revenue (TTM) | 48.03B | Net Income (TTM) | 2.34B |
| ROE | 4.69% | ROA | 5.64% |
| Gross Margin | 13.79% | Operating Margin | 3.34% |
| Net Margin | 4.88% | Free Cash Flow (TTM) | 6.10B |
| ROIC | 7.27% | FCF Growth (3Y) | -6.79% |
| Safety | |||
| Debt / Equity | 0.25 | Current Ratio | 0.89 |
| Interest Coverage | 16.51 | Dividend Yield | 0.38% |
| Valuation | |||
| P/E Ratio | 12.03 | P/B Ratio | 2.13 |
| P/S Ratio | 0.59 | PEG Ratio | 0.00 |
| EV/EBITDA | 13.57 | Dividend Yield | 0.38% |
| Market Cap | 28.20B | Enterprise Value | 21.74B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 48.03B | 240.19B | 179.20B | 147.96B | 101.61B |
| Net Income | 2.34B | 16.63B | 5.31B | 5.26B | 4.85B |
| EPS (Diluted) | 90.60 | 32.60 | 10.20 | 10.00 | 9.60 |
| Gross Profit | 6.62B | 38.20B | 27.42B | 20.90B | 17.41B |
| Operating Income | 1.60B | 8.77B | 3.92B | 1.45B | 2.73B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 41.56B | 229.39B | 192.60B | 157.83B | 134.34B |
| Total Liabilities | 28.16B | 136.97B | 107.45B | 81.63B | 64.12B |
| Shareholders' Equity | 13.22B | 86.74B | 80.51B | 75.13B | 68.61B |
| Total Debt | 3.31B | 6.51B | 8.10B | 13.16B | 4.51B |
| Cash & Equivalents | 9.76B | 40.87B | 35.75B | 33.34B | 28.01B |
| Current Assets | 22.81B | 125.32B | 113.63B | 79.06B | 65.30B |
| Current Liabilities | 25.68B | 127.20B | 96.82B | 68.95B | 60.35B |